Aphora Health, a global healthcare services company, announced the closing of its seed funding round, raising $2.1 million over the past year. The funding will allow Aphora Health to continue to add new products and services and advance its growth into the market as a leading destination healthcare company.
“Since launching in 2023, we have seen significant interest in our company – not only from consumers and employers but from investors as well,” said Aphora Health’s Co-Founder and EVP John Roos. “Investors understand the incredible opportunity international healthcare affords. In 2024, more than $77 billion will flow from the U.S. and Canada to international countries for healthcare. We are in a position to gain a significant share of this market with our unique business model.”
Individual private investors funded the investment seed round with 90% of the proceeds coming from North Carolina investors. Proceeds from the funds will support the continued advancement of Aphora Health’s business and upcoming launch into the employer-self-funded market.
“It’s great to see that investors have recognized how our absolute commitment to quality when curating the world’s best healthcare will bring growth to the company and their investment,” said Jim Song, founder and CEO.
To fund continued growth and expansion, Aphora Health anticipates seeking Series A Funding later in 2024. To learn more about Aphora Health, visit aphorahealth.com.
